Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Mallinckrodt
Healthtrust
Chinese Patent Office
US Army
Chubb
US Department of Justice
Queensland Health
Merck

Generated: December 13, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR EPIPEN E Z PEN

« Back to Dashboard

Clinical Trials for Epipen E Z Pen

Trial ID Title Status Sponsor Phase Summary
NCT00434421 Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma Completed Inner-City Asthma Consortium Phase 1 Immunotherapy may help reduce symptoms of allergy and asthma. Problems concerning compliance and adverse events with subcutaneous allergen immunotherapy have generated interest in delivering immunotherapy sublingually (under the tongue). The purpose of this study is to evaluate the safety of a cockroach extract given sublingually to people with perennial (year-round) allergic rhinitis, with or without asthma.
NCT00434421 Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma Completed National Institute of Allergy and Infectious Diseases (NIAID) Phase 1 Immunotherapy may help reduce symptoms of allergy and asthma. Problems concerning compliance and adverse events with subcutaneous allergen immunotherapy have generated interest in delivering immunotherapy sublingually (under the tongue). The purpose of this study is to evaluate the safety of a cockroach extract given sublingually to people with perennial (year-round) allergic rhinitis, with or without asthma.
NCT00809146 Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications Completed Medical University of South Carolina Phase 3 The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
NCT00809146 Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications Completed National Institute of Neurological Disorders and Stroke (NINDS) Phase 3 The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
NCT00809146 Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications Completed University of California, San Francisco Phase 3 The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Epipen E Z Pen

Condition Name

Condition Name for Epipen E Z Pen
Intervention Trials
Urticaria Chronic 1
Asthma 1
Total Knee Arthroplasty 1
Anaphylaxis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Epipen E Z Pen
Intervention Trials
Rhinitis, Allergic, Perennial 1
Rhinitis, Allergic 1
Multiple Sclerosis 1
Rhinitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Epipen E Z Pen

Trials by Country

Trials by Country for Epipen E Z Pen
Location Trials
United States 16
Sweden 1
Thailand 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Epipen E Z Pen
Location Trials
Maryland 3
Wisconsin 1
Virginia 1
Texas 1
Pennsylvania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Epipen E Z Pen

Clinical Trial Phase

Clinical Trial Phase for Epipen E Z Pen
Clinical Trial Phase Trials
Phase 4 3
Phase 3 2
Phase 1/Phase 2 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Epipen E Z Pen
Clinical Trial Phase Trials
Completed 4
Not yet recruiting 2
Withdrawn 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Epipen E Z Pen

Sponsor Name

Sponsor Name for Epipen E Z Pen
Sponsor Trials
National Institute of Allergy and Infectious Diseases (NIAID) 2
Johns Hopkins University 1
University of California, San Francisco 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Epipen E Z Pen
Sponsor Trials
Other 10
NIH 3
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Teva
Queensland Health
US Department of Justice
AstraZeneca
Cipla
Fuji
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.